AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $134.3 million versus the consensus estimate of $131.25 million.

GUIDANCE:

AtriCure sees FY2025 EPS of ($0.23)-($0.26), versus the consensus of ($0.36). AtriCure sees FY2025 revenue of $532-534 million, versus the consensus of $530.6 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.